Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
9,235 EUR | +0,82% | -30,35% | -56,60% |
26/04 | EVOTEC : da Deutsche Bank è Buy | ZD |
25/04 | EVOTEC : Deutsche Bank è per il Buy | ZD |
Attività
Numero di dipendenti: 5 061
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
EVT Execute
65,8
%
| 547 | 72,8 % | 515 | 65,8 % | -5,89% |
EVT Innovate
34,2
%
| 205 | 27,2 % | 267 | 34,2 % | +30,36% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
59,5
%
| 418 | 55,7 % | 459 | 59,5 % | +9,83% |
Rest of the World
12,3
%
| 127 | 16,9 % | 95 | 12,3 % | -24,91% |
United Kingdom
11,2
%
| 115 | 15,3 % | 86 | 11,2 % | -25,06% |
Switzerland
8,4
%
| - | - | 65 | 8,4 % | - |
Germany
4,4
%
| 59 | 7,8 % | 34 | 4,4 % | -42,04% |
France
4,1
%
| 32 | 4,3 % | 32 | 4,1 % | -0,83% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 07/02/23 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 01/05/12 |
Cord Dohrmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/10 |
Gabriele Hansen
IRO | Public Communications Contact | - | - |
Volker Braun
IRC | Investor Relations Contact | - | - |
Matthias Evers
PRN | Corporate Officer/Principal | 51 | 01/05/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Roland Sackers
BRD | Director/Board Member | 56 | 19/06/19 |
Chairman | 63 | 17/06/14 | |
Elaine Sullivan
BRD | Director/Board Member | 63 | 09/06/15 |
Director/Board Member | 41 | 22/06/22 | |
Director/Board Member | 62 | 01/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 177 542 097 | 160 931 634 ( 90,64 %) | 249 915 ( 0,1408 %) | 90,64 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
EXSCIENTIA PLC 11.86% | 14 035 200 | 11.86% | 80 281 344 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. |
Miscellaneous Commercial Services
|
Aptuit (Verona) Srl
Aptuit (Verona) Srl Pharmaceuticals: MajorHealth Technology Aptuit (Verona) Srl engages in the provision of integrated drug development solutions. It offers Indigo and Indigo-Select. The company was founded in 2004 and is headquartered in Verona, Italy. |
Pharmaceuticals: Major
|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. |
Miscellaneous Commercial Services
|
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. |
Miscellaneous Commercial Services
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-56,60% | 1,75 Mrd | |
+1,51% | 42,75 Mrd | |
+8,57% | 41,34 Mrd | |
+49,22% | 41,61 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione EVT
- Società Evotec SE